These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8291340)

  • 1. [Study of a group of diabetic patients enrolled in the INAMI convention "Self-monitoring of blood glucose"].
    Buysschaert M; Lambert L; Donckier J; Jamart J
    Acta Clin Belg; 1993; 48(5):316-23. PubMed ID: 8291340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating access to glucometer reagents increases blood glucose self-monitoring frequency and improves glycaemic control: a prospective study in insulin-treated diabetic patients.
    Nyomba BL; Berard L; Murphy LJ
    Diabet Med; 2004 Feb; 21(2):129-35. PubMed ID: 14984447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment and glycemic control of 1200 diabetic patients enrolled at the National Institute of Disease-Disability Insurance diabetes convention].
    Buysschaert M; Maes M; Hermans MP
    Acta Clin Belg; 1997; 52(4):211-8. PubMed ID: 9412121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of data management on a central server on HbA1c levels in insulin-requiring patients.
    Davidson MB; Lewis G
    Diabetes Care; 2000 May; 23(5):706-7. PubMed ID: 10834438
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
    Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
    Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I; Álvarez P; García N; Roura G; Conget I;
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
    Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
    Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
    Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glycosylated hemoglobin in diabetic children under 18 years old enrolled in the INAMI study for the purpose of self-monitoring of glucose at home].
    Dorchy H; Roggemans MP; Willems D
    Acta Clin Belg; 1997; 52(6):405-6. PubMed ID: 9489138
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of blood glucose monitoring in relation to glycemic control among patients with type 2 diabetes in the UK.
    Secnik K; Yurgin N; Lage MJ; McDonald-Everett C
    J Diabetes Complications; 2007; 21(3):181-6. PubMed ID: 17493552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
    Puhr S; Calhoun P; Welsh JB; Walker TC
    Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of blood glucose testing among insulin-treated diabetes mellitus patients in the United Kingdom.
    Lee WC; Smith E; Chubb B; Wolden ML
    J Med Econ; 2014 Mar; 17(3):167-75. PubMed ID: 24359593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring glycemia in diabetes.
    Healy SJ; Dungan KM
    Med Clin North Am; 2015 Jan; 99(1):35-45. PubMed ID: 25456642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).
    Sartore G; Chilelli NC; Burlina S; Di Stefano P; Piarulli F; Fedele D; Mosca A; Lapolla A
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S153-60. PubMed ID: 22466072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain.
    Lecumberri Pascual E; Tejera Pérez C; Muñoz-Garach A; Javier Ampudia-Blasco F
    Diabetes Res Clin Pract; 2019 Aug; 154():43-51. PubMed ID: 31226281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.